Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Venkatesh Pilla Reddy

19PUBLICATIONS

118CO-AUTHORS

Clinical pharmacology and therapeuticsMolecular targetsPharmaceutical delivery technologiesPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Mar 20, 2025

ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global Convergence.

Kellie Reynolds, Xinning Yang, Sheila Annie Peters

|Mar 05, 2025

Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach.

Innocent Gerald Asiimwe, Nour Chtiba, Samer Mouksassi

|Oct 18, 2024

Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.

Micaela B Reddy, Tamara D Cabalu, Loeckie de Zwart

|Nov 16, 2022

Evaluating the performance of machine-learning regression models for pharmacokinetic drug-drug interactions.

Jaidip Gill, Marie Moullet, Anton Martinsson

|Sep 30, 2022

Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction prediction.

Jaidip Gill, Marie Moullet, Anton Martinsson

|Jul 07, 2022

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection.

Rachel A Bender Ignacio, David A Wohl, Rosalin Arends

Pageof 4

Frequent Collaborators

3 joint publications

Sibylle Neuhoff

2 joint publications

Stephen T Durant

2 joint publications

Filip Miljković

2 joint publications

Rosalinda H Arends

2 joint publications

Anton Martinsson

2 joint publications

Erica Banks

2 joint publications

Jason G Kettle

1 joint publications

Li Zheng

1 joint publications

Andrew Sykes

1 joint publications

Annika Janefeldt

Frequent Collaborators

3 joint publications

Sibylle Neuhoff

2 joint publications

Stephen T Durant

2 joint publications

Filip Miljković

2 joint publications

Rosalinda H Arends

Top Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on : Jun 21, 2018

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on : May 04, 2017

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

See more related videos

Top Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on : Jun 21, 2018

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on : May 04, 2017

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

See more related videos